1. Home
  2. STIM vs JHI Comparison

STIM vs JHI Comparison

Compare STIM & JHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$1.23

Market Cap

140.6M

Sector

Health Care

ML Signal

HOLD

Logo John Hancock Investors Trust

JHI

John Hancock Investors Trust

HOLD

Current Price

$13.21

Market Cap

116.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
STIM
JHI
Founded
2003
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
140.6M
116.0M
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
STIM
JHI
Price
$1.23
$13.21
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
1.6M
12.5K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
57.25
N/A
EPS
N/A
N/A
Revenue
$52,776,000.00
N/A
Revenue This Year
$11.10
N/A
Revenue Next Year
$11.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$12.50
52 Week High
$4.84
$14.51

Technical Indicators

Market Signals
Indicator
STIM
JHI
Relative Strength Index (RSI) 42.89 48.02
Support Level $1.21 $12.93
Resistance Level $1.75 $13.56
Average True Range (ATR) 0.12 0.13
MACD -0.01 -0.01
Stochastic Oscillator 7.27 37.50

Price Performance

Historical Comparison
STIM
JHI

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

About JHI John Hancock Investors Trust

John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others. The company's portfolio includes Corporate Bonds, Term Loans, U.S Government Agency, and Others.

Share on Social Networks: